Diagnostic dilemmas in a patient with anaemia. Empty sella syndrome - a case report by Holecki, Michał et al.
400
OPISY PRZYPADKÓW/CASE REPORTS
Endokrynologia Polska/Polish Journal of Endocrinology
Tom/Volume 61; Numer/Number 4/2010
ISSN 0423–104X
Michał Holecki M.D., Ph.D., Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, Ziołowa St. 45/47,
40–635 Katowice, e-mail: holomed@poczta.onet.pl
Diagnostic dilemmas in a patient with anaemia.
Empty sella syndrome — a case report
Dylematy diagnostyczne u chorego z niedokrwistością.
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Abstract
Empty sella syndrome is defined as a group of clinical symptoms developing as a result of herniation of the subarachnoid space within the
sella, which is often associated with some degree of flattening of the pituitary gland. It is usually recognized incidentally during brain
imaging studies performed for different indications, and in most cases this condition is asymptomatic. However, it may result in impair-
ment of various endocrine glands, for which the pituitary gland produces its crinins. Despite the high incidence of empty sella syndrome
(up to about 5% of the population) it is commonly ignored as the cause of various symptoms. We present a case of 55-year-old patient
admitted to the department of internal medicine due to anaemia and progressive weakness, with recognized hypothyroidism and adrenal
gland insufficiency in the course of empty sella syndrome. (Pol J Endocrinol 2010; 61 (4): 400–403)
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Streszczenie
Zespół pustego siodła definiuje się jako grupę objawów klinicznych rozwijających się w wyniku wpuklania się przestrzeni podpajęczy-
nówkowej do siodła tureckiego, co często powoduje ucisk przysadki. Zespół ten zwykle rozpoznaje się przypadkowo podczas badań
obrazowych mózgu przeprowadzonych z różnych wskazań i w większości przypadków nie powoduje on żadnych objawów. Czasami
jednak skutkuje on zaburzeniami czynności różnych gruczołów wydzielania wewnętrznego, spowodowanymi upośledzeniem produkcji
przez przysadkę hormonów tropowych dla tych gruczołów. Mimo stosunkowo częstego występowania zespołu pustego siodła (u ok.
5% populacji), zwykle nie bierze się go pod uwagę jako możliwej przyczyny różnych symptomów. W niniejszej pracy przedstawiono
przypadek 55-letniego pacjenta, przyjętego na oddział chorób wewnętrznych z powodu niedokrwistości i postępującego osłabienia,
u którego rozpoznano niedoczynność tarczycy i niewydolność kory nadnerczy w przebiegu zespołu pustego siodła.
(Endokrynol Pol 2010; 61 (4):  400–403)
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Introduction
Empty sella syndrome, documented for the first time
in 1951 by Busch et al., is defined as a group of clinical
symptoms developing as a result of herniation of the
subarachnoid space within the sella, which is often as-
sociated with some degree of flattening of the pituitary
gland [1–3]. There are two classical types of empty sella
syndrome: primary and secondary. The aetiology of the
primary empty sella (PES) is associated with congenital
incomplete formation of the sellar diaphragm, which is
associated with increased intracranial pressure that can
be stable or intermittent. In the case of secondary emp-
ty sella syndrome, it may be caused by various patho-
logical conditions such as: pituitary adenomas under-
going spontaneous (ischaemia, haemorrhage) or in-
duced (pharmacotherapy) necrosis or by radiotherapy,
neurosurgery, or infections [4]. PES is more common in
women with arterial hypertension and is usually found
incidentally during CT/MRI examination performed for
the other indications. In autopsies, PES occurrence rates
amount to 6–20% [5]. In most cases, the clinical course
is asymptomatic. In 20–50% of cases, patients present
with endocrine abnormalities: partial hypopituitarism
(5%), total hypopituitarism (25%), or hyperprolacti-
naemia (10%) [4–7]. Slow development of hypopituitar-
ism constitutes the most common feature of described
clinically-overt cases. The insidious onset significantly
delays the diagnosis and makes it difficult and compli-
cated.
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A case report
A 55-year-old man was admitted to hospital in March
2009 because of anaemia, progressive weakness, weight
loss, dizziness, and musculoskeletal pain with progress-
ing intensity for several months. The patient’s history
included: peptic ulcer disease, haemorrhage of the up-
per GI tract, chronic pancreatitis (the patients had for-
merly been hospitalized in the Surgery Department
several times), and diabetes mellitus type 2 (diagnosed
two years earlier). In 1996 (at the age of 42) the patient
had myocardial infarction, which appeared to be the
first symptom of coronary artery disease. In 2002 he
underwent percutaneous coronary angioplasty of the
circumflex branch of the left coronary artery and the
marginal branch of the right coronary artery, along with
a stent implantation into the anterior descending ar-
tery. Four months before admittance to the hospital the
patient discontinued treatment with bisoprolol and ni-
trates because of low blood pressure. It is worth noting
that the patient’s mother had a history of lung cancer.
Despite this fact, the patient smoked 30–40 cigarettes
daily. His laboratory findings (performed ambulatory)
included anaemia (haemoglobin level of 10.5 g/dL) and
positive occult blood test. The patient’s clinical and fam-
ily history along with the results of the laboratory find-
ings suggested that his complaints may have resulted
from cancer.
In the physical examination there were no signifi-
cant abnormalities except attenuation of tendon reflex-
es in the lower extremities and disturbances of superfi-
cial sensibility of the left upper extremity, correspond-
ing to radial nerve damage.
In routine laboratory findings (Table IA and IB) we
found anaemia, low iron level, normal total cholester-
ol, LDL cholesterol, and triglyceride levels. The occult
blood test was negative. We did not reveal the pres-
ence of parasites in the stool. The level of antinuclear
antibodies was within the normal range. Radiological
examinations (chest x-ray, ultrasound of: abdominal
cavity, pelvic cavity, and thyroid gland, and CT of ab-
dominal cavity) and oesophagoscopy of the upper GI
tract showed no significant abnormalities except many
calcifications in the pancreas (probably as a result of
chronic pancreatitis) and hiatal hernia. Since laborato-
ry and radiological examinations did not explain the
source of the patient’s complaints, we considered hor-
monal disturbances in differential diagnosis. Laborato-
ry tests of the pituitary — thyroid axis (Table II) sug-
gested secondary hypothyroidism. An additional test
of the pituitary — adrenal axis, pituitary - gonadal axis,
and prolactin level showed diminished endocrine func-
tion of the pituitary gland (Table II). MRI imaging of
Table IA. Results of laboratory findings
Tabela IA. Wyniki badań laboratoryjnych
Blood cell count Results
Leucocytes (× 103/L) 7.2
Erythrocytes (× 106/L) 3.8
Haemoglobin level [g/dL] 11
Hematocrit (%) 32.4
Blood smear
Neutrophiles (%) 64.2
Basophiles (%) 3.1
Eosinophiles (%) 9.2
Lymphocytes (%) 6.4
Monocytes (%) 3.6
Serum level of
Phosphorus [mg/dL] 4.2
Total calcium [mg/dL] 9.7
Sodium [mmol/L] 139
Potassium [mmol/L] 4.3
Iron [ug/dL] 49
Total protein [g/L] 6.1
Bilirubin [mg/dL] 0.4
Creatinine [mg/dL] 0.83
Glucose [mg/dL] 67
HbA1c (%) 6.1
Table IB. Results of laboratory findings
Tabela IB. Wyniki badań laboratoryjnych
Serum activity of Results
ALT [U/L] 11
SGOT [U/L] 23
GGTP [U/L] 16
AP [U/L] 72
sAlpha-amylase [U/L] 61
CPK [U/L] 94
Serum level of
Antibody ds DNA [IU/mL] 14.1
ANA [RU/mL] 3.8
antigen Ca 19.9 [u/mL] <3
Vitamin B12 [pg/mL] 280
Folic acid [ng/mL] 4.8
Total cholesterol [mg/dL] 164
HDL [mg/dL] 46
LDL [mg/dL] 103
TGL [mg/dL] 74
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the pituitary gland suggested the occurrence of a sub-
arachnoid pouch in the sellar and suprasellar region.
The anterior lobe of the pituitary gland was significant-
ly thinned, hypothalamic infundibulum was displaced
by a subarachnoid pouch in the right side, and com-
pression of the optic chiasm was observed. The patient
was provided with levothyroxine (50 ug/24 h) and hy-
drocortisone (20 mg/24h). After seven days of hormon-
al supplementation, significant improvement in the
patient’s clinical condition was observed. The patient
was seen by physicians from the Neurosurgery Depart-
ment, who decided to continue with noninvasive treat-
ment. Then patient was systematically seen and evalu-
ated at an Outpatient Ambulatory Clinic. Two months
later the patient complained of blurred vision (mainly
on the right side) and vertigo, which were absolute in-
dications for surgical intervention. The patient was op-
erated with the use of endoscopic technology without
any complications. Five months after surgical treatment
the patient feels well and does not report any com-
plaints. The results of laboratory findings are within the
normal range (Table III).
Discussion
As was already stated, PES may be clinically asymptom-
atic and discovered as an „incidental” finding. On the
other hand, it may produce symptoms associated with
diminished endocrine function of the pituitary gland
(ranking from mild insufficiency to severe hypometa-
bolic crisis) or with severe intracranial hypertension and
rhinorrhea [8]. In the case of the asymptomatic course,
patients are unlikely to develop progression of endo-
crine or neurologic abnormalities in a follow up, and
results of radiological examination tend to remain un-
changed. It is reasonable to re-evaluate patients every
24–26 months [4]. There are many clinical conditions
that could promote the onset of secondary empty sella,
such as: obesity (coexistence of hypercapnia increases
the intracranial pressure), pregnancy (coexistence of
hypoplastic sellar diaphragm and higher pituitary vol-
ume of up to 2–3 times, particularly in the case of mul-
tiple pregnancy), diabetes mellitus type 2, arterial hy-
pertension, or the use of some drugs [9–11]. Weakness
(with coexistence of anaemia) was the primary com-
plaint of our patient. His clinical and family history
strongly suggested neoplastic disease. With this suspect-
ed diagnosis, the patient was admitted to the Depart-
ment of Internal Medicine. However, anaemia is also
a frequent finding in hypopituitarism, and treatment with
levothyroxine and hydrocortisone leads to a rapid im-
provement in haemoglobin levels [12]. The second most
common laboratory alteration in patients with PES is
slight hyperprolactinaemia with the association of sec-
ondary hypogonadism (observed in our patient) [4]. The
third common alteration (not seen in our patient) is hy-
ponatraemia to varying degrees. Hypopituitarism is
a frequently overlooked cause of severe hyponatraemia
[13]. According to Diederich et al., unrecognized hy-
popituitarism is the cause of about 20% of cases of that
alteration [14]. The presented case is a good example of
the diagnostic dilemmas of both anaemia and empty
sella syndrome. Differential diagnosis of anaemia had
lasted for at least several months before admittance to
our department. It appeared that the key point in the
diagnostic process was the exclusion of neoplastic dis-
ease, even though the occult test was positive, and so
was the test for endocrine abnormalities — laboratory
findings that suggested dysfunction of the pituitary
gland and determined the diagnostic and therapeutic
management.
Despite the high prevalence of PES (about 5% of the
population) [15], this condition is frequently overlooked
Table III. Results of laboratory findings 5 months after
surgical procedure and during thyroid and adrenal gland
hormone supplementation
Table III. Wyniki badań laboratoryjnych wykonanych
5 miesięcy po zabiegu chirurgicznym, w trakcie substytucyjnego
leczenia niedoczynności tarczycy i kory nadnerczy
Laboratory finding Result Range
TSH [uUI/mL] 0.5 (0.35–5.0)
fT4 [pmol/L] 16 (9–20)
Cortisol (8.00) [ug/mL] 14 (6–28)
Erythrocytes (× 106/L) 4.5 (3.5–5.3)
Hemoglobin level [g/dL] 13.5 (11–18)
Table II. Results of hormonal assay
Tabela II. Wyniki badań hormonalnych
Hormone Serum level Range
TSH [uUI/mL] 0.28 (0.35–5.0)
fT3 [pmol/L] 2.9 (4–8.3)
fT4 [pmol/L] 3.8 (9–20)
ACTH [pg/mL] 28.1 (10–60)
LH [IU/L] 0.84 (1.5–10)
Prolactin [mIU/L] 560 (78–461)
DHEAs [ug/dL] 93.8 (130–410)
Testosterone [nmol/L] 0.2 (8.2–34)
Cortisol ( 8.00) [ug/mL] 1.4 (6–28)
Cortisol (18.00) [ug/mL] 0.5 (4–15)
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as the cause of various clinical symptoms. It should be
emphasized that this disease is a multifaceted condi-
tion. On one hand it may be clinically silent, but on the
other it may lead to endocrine deficiency of varying
degrees. In the case of our patient, we faced the prob-
lem of hypothyroidism and adrenal insufficiency, which
were direct causes of anaemia.
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